Verastem Inc (VSTM) concluded trading on Tuesday at a closing price of $5.17, with 15.16 million shares of worth about $78.38 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 76.15% during that period and on December 31, 2024 the price saw a gain of about 40.87%. Currently the company’s common shares owned by public are about 40.26M shares, out of which, 39.64M shares are available for trading.
Stock saw a price change of 30.56% in past 5 days and over the past one month there was a price change of -3.18%. Year-to-date (YTD), VSTM shares are showing a performance of -36.49% which decreased to -36.49% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $2.10 but also hit the highest price of $14.22 during that period. The average intraday trading volume for Verastem Inc shares is 1.07 million. The stock is currently trading 11.57% above its 20-day simple moving average (SMA20), while that difference is up 22.59% for SMA50 and it goes to -1.47% lower than SMA200.
Verastem Inc (NASDAQ: VSTM) currently have 40.26M outstanding shares and institutions hold larger chunk of about 49.90% of that.
The stock has a current market capitalization of $324.15M and its 3Y-monthly beta is at 0.29. It has posted earnings per share of -$3.19 in the same period. It has Quick Ratio of 3.23 while making debt-to-equity ratio of 1.29. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for VSTM, volatility over the week remained 11.36% while standing at 9.79% over the month.
Stock’s fiscal year EPS is expected to rise by 24.15% while it is estimated to increase by 15.02% in next year. EPS is likely to shrink at an annualized rate of 1.74% for next 5-years, compared to annual growth of 24.76% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by BTIG Research on December 31, 2024 offering a Buy rating for the stock and assigned a target price range of between $13 and $20 to it. Coverage by Guggenheim stated Verastem Inc (VSTM) stock as a Buy in their note to investors on September 30, 2024, suggesting a price target of $13 for the stock. On November 21, 2023, BTIG Research Resumed their recommendations, while on September 27, 2023, B. Riley Securities Initiated their ratings for the stock with a price target of $21. Stock get a Buy rating from Mizuho on June 15, 2023.
